Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-02 Sale |
2022-03-04 4:10 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
4,849 | $12.01 | $58,236 | 238,665 (Direct) |
View |
| 2021-10-25 Sale |
2021-10-26 4:33 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
130,000 | $29.75 | $3,867,500 | 69,592 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-22 4:53 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
32,500 | $23.99 | $779,533 | 199,592 (Direct) |
View |
| 2021-09-10 Sale |
2021-09-14 5:12 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
32,500 | $21.15 | $687,325 | 106,092 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-08 4:03 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
5,000 | $18.3 | $91,500 | 138,592 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-02 Option Award |
2022-03-04 4:10 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
177,786 | $0 | 238,665 (Direct) |
View |
| 2021-10-25 Exercise |
2021-10-26 4:33 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
95,000 | $3.2 | 69,592 (Direct) |
View |
| 2021-10-25 Exercise |
2021-10-26 4:33 pm |
N/A 2027-02-09 |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
95,000 | $0 | 69,592 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:53 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
11,136 | $3.2 | 199,592 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:53 pm |
N/A 2022-12-11 |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
27,136 | $0 | 199,592 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:53 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
16,000 | $2.63 | 199,592 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-11 5:22 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research |
40,000 | $3.02 | 143,592 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-11 5:22 pm |
N/A 2021-03-30 |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research |
40,000 | $0 | 143,592 (Direct) |
View |
Ownership |
2021-01-04 5:58 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research |
0 | $0 | 719,285 (Direct) |
View |